WNY1613 - CAS 2650546-39-5

WNY1613 is a potent and selective PI3Kδ inhibitor with a piperazinone-containing purine scaffold, exhibiting anti-NHL effects both in vitro and in vivo by inhibiting phosphorylation of downstream components of PI3K in NHL cell lines and inducing apoptosis in cancer cells.

Others, PI3K, Apoptosis

PI3K/Akt/mTOR signaling, Apoptosis, Others

2650546-39-5

C29H35N9O3

557.65

C(C)C=1N(C=2C(N1)=CC=CC2)C3=NC(=C4C(=N3)N(C)C(CN5C(=O)CN(C(=O)C6CCC6)CC5)=N4)N7CCOCC7

-20°C

Ice Packs

Small Compound